Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2005-02-01
2005-02-01
Desai, Rita (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S269000, C514S274000, C514S365000, C514S422000, C514S300000, C514S301000, C514S342000, C514S339000, C514S340000, C514S343000, C514S330000, C514S327000, C514S307000, C514S414000, C514S254010, C514S253010, C514S255010, C514S255050, C514S372000, C514S237200, C514S233500, C514S235800, C544S349000, C544S365000, C544S121000, C544S122000, C544S124000, C544S129000, C544S141000, C544S142000, C544S143000, C544S060000, C544S295000, C544S296000, C544S300000, C546S114000, C546S113000, C546S141000, C546S146000, C546S
Reexamination Certificate
active
06849622
ABSTRACT:
The present invention is to provide an aliphatic nitrogen-containing 5-membered ring compound represented by the formula [I]:whereinA represents —CH2— or —S—,R1represents hydrogen atom, a lower alkyl group, a hydroxy lower alkyl group or a lower alkoxy lower alkyl group,X represents —N(R3)—, —O— or —CO—, where R3represents hydrogen atom or a lower alkyl group, andR2represents (1) a cyclic group which may be substituted, or (2) an amino group which may be substituted,or a pharmaceutically acceptable salt thereof, a method for preparing the above-mentioned compound and a pharmaceutical composition comprising the above-mentioned compound as an effective ingredient.
REFERENCES:
patent: 6011155 (2000-01-01), Villhauer
patent: 6107317 (2000-08-01), Villhauer
patent: 6110949 (2000-08-01), Villhauer
patent: 6432969 (2002-08-01), Villhauer
patent: WO 9819998 (1998-05-01), None
patent: WO 0034241 (2000-06-01), None
patent: WO 0196295 (2001-12-01), None
patent: WO 02051836 (2002-07-01), None
Augustyns, K., et al., The Unique Properties of Dipeptidyl-peptidase IV (DPP IV / CD 26) and the Therapeutic Potential of DPP IV Inhibitors,Current Medicinal Chemistry,pp. 311-327 (1999).
Arakawa Kenji
Hikota Masataka
Kawanami Saburo
Matsumoto Takeshi
Morimoto Hiroshi
Desai Rita
Shiao Robert
Tanabe Seiyaku Co. Ltd.
LandOfFree
Aliphatic nitrogenous five-membered ring compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Aliphatic nitrogenous five-membered ring compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Aliphatic nitrogenous five-membered ring compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3501688